{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T16:08:59Z","timestamp":1795277339841,"version":"4.10.3"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Remimazolam is a novel benzodiazepine anesthetic\/sedative, designed as a rapidly metabolized carboxylic acid. Since its recent launch, the role of remimazolam in modern anesthesia and sedation practice is still evolving. This review aims to outline the clinical pharmacology and clinical utility of remimazolam to elucidate its potential advantages and limitations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Remimazolam is \u201cshort-acting\u201d but not ultra-short-acting compared with propofol based on context-sensitive decrement times. But compared to propofol, the availability of the benzodiazepine antagonist, flumazenil, is considered an advantage, particularly in certain emergency situations such as in patients with difficult airways. However, because flumazenil is shorter acting than remimazolam when remimazolam accumulates or is present in a high concentration, the reappearance of remimazolam sedation may occur after the initial reversal of anesthesia\/sedation from flumazenil administration. Although it is beneficial that remimazolam causes less respiratory depression and hypotension than propofol, serious respiratory depression and hypotension can still occur. Remimazolam administration causes minimal or no pain on injection. Remimazolam is associated with less postoperative nausea and vomiting than inhaled anesthetics, but propofol is clearly superior in this regard. The anesthetic\/sedative effects may be prolonged by severe hepatic impairment; remimazolam tolerance can occur in long-term benzodiazepine users.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Remimazolam may be beneficial to use in procedural sedation and general anesthesia for patients with difficult airways or hemodynamic instability. Further clinical studies with remimazolam are warranted to identify the potential benefits in other settings and patient populations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000001384","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T10:15:06Z","timestamp":1717668906000},"page":"344-351","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice"],"prefix":"10.1097","volume":"37","author":[{"given":"Kenichi","family":"Masui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"R1-20250601","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00540-020-02755-1","article-title":"Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!","volume":"34","author":"Masui","year":"2020","journal-title":"J Anesth"},{"key":"R2-20250601","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.2147\/DDDT.S384155","article-title":"Remimazolam: an updated review of a new sedative and anaesthetic","volume":"16","author":"Hu","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"R3-20250601","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/ACO.0000000000000879","article-title":"Soft drugs in anesthesia: remifentanil as prototype to modern anesthetic drug development","volume":"33","author":"Birgenheier","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"key":"R4-20250601","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/ALN.0b013e3181ae8460","article-title":"Is anesthesiology going soft? Trends in fragile pharmacology","volume":"111","author":"Egan","year":"2009","journal-title":"Anesthesiology"},{"key":"R5-20250601","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/bja\/aex320","article-title":"Getting the dose right: anaesthetic drug delivery and the posological sweet spot","volume":"119","author":"Kuck","year":"2017","journal-title":"Br J Anaesth"},{"key":"R6-20250601","doi-asserted-by":"crossref","first-page":"690875","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent","volume":"12","author":"Kilpatrick","year":"2021","journal-title":"Front Pharmacol"},{"key":"R7-20250601","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00000542-199311000-00005","article-title":"Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery","volume":"79","author":"Westmoreland","year":"1993","journal-title":"Anesthesiology"},{"key":"R8-20250601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17085\/apm.21115","article-title":"Remimazolam: pharmacological characteristics and clinical applications in anesthesiology","volume":"17","author":"Kim","year":"2022","journal-title":"Anesth Pain Med (Seoul)"},{"key":"R10-20250601","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"R11-20250601","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00228-019-02800-3","article-title":"Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers","volume":"76","author":"Sheng","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"R12-20250601","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00540-022-03079-y","article-title":"A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice","volume":"36","author":"Masui","year":"2022","journal-title":"J Anesth"},{"key":"R13-20250601","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00540-022-03099-8","article-title":"Equilibration rate constant, ke0, to determine effect-site concentration for the Masui remimazolam population pharmacokinetic model in general anesthesia patients","volume":"36","author":"Masui","year":"2022","journal-title":"J Anesth"},{"key":"R14-20250601","first-page":"190","article-title":"What is its context-sensitive half-life? (Japanese)","author":"Masui","year":"2015","journal-title":"Answers to clinical questions: intravenous anesthesia Q&A99"},{"key":"R15-20250601","doi-asserted-by":"crossref","first-page":"111223","DOI":"10.1016\/j.jclinane.2023.111223","article-title":"Comparison of propofol vs. remimazolam on emergence profiles after general anesthesia: a randomized clinical trial","volume":"90","author":"Oh","year":"2023","journal-title":"J Clin Anesth"},{"key":"R16-20250601","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00540-021-02915-x","article-title":"Re-sleeping after reversal of remimazolam by flumazenil","volume":"35","author":"Yamamoto","year":"2021","journal-title":"J Anesth"},{"key":"R17-20250601","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/00000542-199704000-00014","article-title":"Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers","volume":"86","author":"Glass","year":"1997","journal-title":"Anesthesiology"},{"key":"R18-20250601","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2199\/jjsca.34.860","article-title":"Remimazolam","volume":"34","author":"Doi","year":"2014","journal-title":"J Japan Soc Clin Anesthesia"},{"key":"R19-20250601","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/EJA.0000000000001904","article-title":"Assessment of explicit and implicit memories during remimazolam anaesthesia using the process dissociation procedure: a prospective cohort study","volume":"40","author":"Kim","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"R20-20250601","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10877-015-9805-5","article-title":"Monitoring sleep depth: analysis of bispectral index (BIS) based on polysomnographic recordings and sleep deprivation","volume":"31","author":"Gim\u00e9nez","year":"2017","journal-title":"J Clin Monit Comput"},{"key":"R21-20250601","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/ALN.0000000000003102","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part II. pharmacodynamics of electroencephalogram effects","volume":"132","author":"Eisenried","year":"2020","journal-title":"Anesthesiology"},{"key":"R22-20250601","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bja.2023.07.023","article-title":"The art of chasing numbers in titration of anaesthetic dose","volume":"131","author":"Sleigh","year":"2023","journal-title":"Br J Anaesth"},{"key":"R23-20250601","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40981-023-00638-4","article-title":"Successful reversal of remimazolam anesthesia in a \u201ccannot intubate, can ventilate\u201d situation: a case report","volume":"9","author":"Sekimoto","year":"2023","journal-title":"JA Clin Rep"},{"key":"R24-20250601","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00540-021-03021-8","article-title":"Comparison of remimazolam and propofol in anesthetic management for awake craniotomy: a retrospective study","volume":"36","author":"Sato","year":"2022","journal-title":"J Anesth"},{"key":"R25-20250601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00540-022-03107-x","article-title":"Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risks","volume":"37","author":"Masui","year":"2023","journal-title":"J Anesth"},{"key":"R26-20250601","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy","volume":"88","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"R27-20250601","doi-asserted-by":"crossref","DOI":"10.1002\/9780471462422.eoct322","article-title":"Therapeutic Index","author":"Abughazaleh","year":"2007","journal-title":"In Wiley Encyclopedia of Clinical Trials"},{"key":"R28-20250601","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial","volume":"34","author":"Doi","year":"2020","journal-title":"J Anesth"},{"key":"R29-20250601","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12871-021-01530-3","article-title":"Remimazolam for induction of anesthesia in elderly patients with severe aortic stenosis: a prospective, observational pilot study","volume":"21","author":"Nakanishi","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"R30-20250601","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12871-023-01974-9","article-title":"Comparison of hemodynamics during induction of general anesthesia with remimazolam and target-controlled propofol in middle-aged and elderly patients: a single-center, randomized, controlled trial","volume":"23","author":"Sekiguchi","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R31-20250601","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/EJA.0b013e328349b7f5","article-title":"Part 1: pathophysiology and risk factors","volume":"28","author":"Steiner","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"R32-20250601","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00540-022-03119-7","article-title":"Association between remimazolam and postoperative delirium in older adults undergoing elective cardiovascular surgery: a prospective cohort study","volume":"37","author":"Aoki","year":"2023","journal-title":"J Anesth"},{"key":"R33-20250601","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00540-022-03148-2","article-title":"Effect of remimazolam on the incidence of delirium after transcatheter aortic valve implantation under general anesthesia: a retrospective exploratory study","volume":"37","author":"Kaneko","year":"2023","journal-title":"J Anesth"},{"key":"R34-20250601","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/DDDT.S392569","article-title":"Effect of remimazolam on postoperative delirium in older adult patients undergoing orthopedic surgery: a prospective randomized controlled clinical trial","volume":"17","author":"Yang","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"R35-20250601","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/EJA.0000000000000594","article-title":"European Society of Anaesthesiology evidence- based and consensus-based guideline on postoperative delirium","volume":"34","author":"Aldecoa","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"R36-20250601","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/ALN.0b013e318289b84b","article-title":"Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15","volume":"118","author":"Stark","year":"2013","journal-title":"Anesthesiology"},{"key":"R37-20250601","doi-asserted-by":"crossref","first-page":"110955","DOI":"10.1016\/j.jclinane.2022.110955","article-title":"Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: a randomized noninferiority trial","volume":"82","author":"Choi","year":"2022","journal-title":"J Clin Anesth"},{"key":"R38-20250601","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12871-023-02091-3","article-title":"Comparison of postoperative nausea and vomiting between remimazolam and propofol in patients undergoing oral and maxillofacial surgery: a prospective randomized controlled trial","volume":"23","author":"Kim","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R39-20250601","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.bja.a013366","article-title":"Validity and reliability of the postoperative quality of recovery score: QoR-40","volume":"84","author":"Myles","year":"2000","journal-title":"Br J Anaesth"},{"key":"R40-20250601","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12871-022-01770-x","article-title":"Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial","volume":"22","author":"Song","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R41-20250601","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ALN.0000000000001158","article-title":"Minimal clinically important difference for three quality of recovery scales","volume":"125","author":"Myles","year":"2016","journal-title":"Anesthesiology"},{"key":"R42-20250601","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","article-title":"Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy","volume":"155","author":"Pastis","year":"2019","journal-title":"Chest"},{"key":"R43-20250601","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12871-021-01373-y","article-title":"Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"R44-20250601","first-page":"963","article-title":"Prevention of pain on injection with propofol: a quantitative systematic review","volume":"90","author":"Picard","year":"2000","journal-title":"Anesth Analg"},{"key":"R45-20250601","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"R46-20250601","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4097\/kja.22441","article-title":"Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study","volume":"76","author":"Suzuki","year":"2023","journal-title":"Korean J Anesthesiol"},{"key":"R47-20250601","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00540-022-03041-y","article-title":"Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery","volume":"36","author":"Hari","year":"2022","journal-title":"J Anesth"},{"key":"R48-20250601","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12871-022-01835-x","article-title":"Prevention of postoperative nausea and vomiting after gynaecological day surgery under remimazolam general anesthesia: a randomized double-blind controlled study","volume":"22","author":"Yi","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R49-20250601","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00540-022-03112-0","article-title":"The intraoperative motor-evoked potential when propofol was changed to remimazolam during general anesthesia: a case series","volume":"37","author":"Yamada","year":"2023","journal-title":"J Anesth"},{"key":"R50-20250601","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00540-022-03159-z","article-title":"Effect of remimazolam on intraoperative neurophysiology monitoring of visual-evoked potential: a case series","volume":"37","author":"Yamada","year":"2023","journal-title":"J Anesth"},{"key":"R51-20250601","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00381-023-05900-9","article-title":"Comparison of intraoperative neurophysiological monitoring methods for lumbosacral lipoma surgery in infants","volume":"39","author":"Nonaka","year":"2023","journal-title":"Childs Nerv Syst"},{"key":"R52-20250601","first-page":"e27593","article-title":"A case of decreased amplitude in motor evoked potentials under remimazolam anesthesia","volume":"14","author":"Aratani","year":"2022","journal-title":"Cureus"},{"key":"R53-20250601","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1111\/j.1365-2125.1983.tb02270.x","article-title":"Pharmacokinetics and bioavailability of midazolam in man","volume":"16","author":"Heizmann","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"R54-20250601","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2125.2002.01588.x","article-title":"Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers","volume":"53","author":"Knoester","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R55-20250601","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00228-020-02984-z","article-title":"Pharmacokinetics and pharmacodynamics of intranasal remimazolam-a randomized controlled clinical trial","volume":"76","author":"Pesic","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"R56-20250601","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40268-020-00317-0","article-title":"Remimazolam has low oral bioavailability and no potential for misuse in drug-facilitated sexual assaults, with or without alcohol: results from two randomised clinical trials","volume":"20","author":"Pesic","year":"2020","journal-title":"Drugs R D"},{"key":"R57-20250601","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","article-title":"Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment","volume":"127","author":"Stohr","year":"2021","journal-title":"Br J Anaesth"},{"key":"R58-20250601","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/DDDT.S186759","article-title":"Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system","volume":"13","author":"Freyer","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R59-20250601","first-page":"415","article-title":"Delayed emergence after remimazolam induction in end-stage liver disease. Comment on Br J Anaesth","volume":"127","author":"Singal","year":"2021"},{"key":"R60-20250601","doi-asserted-by":"crossref","first-page":"e01460","DOI":"10.1213\/XAA.0000000000001460","article-title":"Remimazolam tolerance in long-term benzodiazepine users: a case report of 2 cases","volume":"15","author":"Yoshikawa","year":"2021","journal-title":"A&A Pract"},{"key":"R61-20250601","first-page":"e42576","article-title":"Two cases of inadequate response to remimazolam","volume":"15","author":"Kitaura","year":"2023","journal-title":"Cureus"},{"key":"R62-20250601","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00540-022-03139-3","article-title":"Tolerance to remimazolam at a high effect-site concentration","volume":"37","author":"Kida","year":"2023","journal-title":"J Anesth"},{"key":"R63-20250601","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/ALN.0000000000004811","article-title":"Target-controlled infusion of remimazolam in healthy volunteers shows some acute tolerance","volume":"140","author":"Vellinga","year":"2024","journal-title":"Anesthesiology"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:01:44Z","timestamp":1748815304000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001384","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}